Abstract: Process for reducing hexavalent chromium in oxidic solids, which comprises the steps: a) heating of the oxidic solid containing Cr(VI) to a temperature of from 600 to 1400° C. in an atmosphere containing less than 0.1% by volume of an oxidizing gas and b) cooling of the reaction product obtained after step a) to a temperature below 100° C. in an atmosphere containing less than 0.1% by volume of an oxidizing gas, characterized in that no reducing agent is added to the oxidic solid or to the atmosphere in step a) and b) in the process.

Abstract: Process for reducing hexavalent chromium in oxidic solids, which comprises the steps: a) mixing of the oxidic solid containing Cr(VI) with a carbon-containing compound which is liquid in the range from 20 to 100° C., b) treatment of the mixture obtained after a) in an indirectly heated reactor at a temperature of from 700° C. to 1100° C., particularly preferably at a temperature of from 800° C. to 1000° C., under a protective atmosphere, c) cooling of the reaction product obtained after b) to at least 300° C., preferably at least 150° C., under a protective atmosphere.

Abstract: The present invention relates to a process for preparing chromium(III) oxide by reaction of alkali metal chromate with gaseous ammonia, subsequent hydrolysis, isolation of the hydrolysis product and calcination.

Abstract: Process for preparing chromium(III) oxide, which comprises the steps: a) reaction of sodium monochromate with gaseous ammonia, in particular at a temperature of from 200 to 800° C., b) hydrolysis of the reaction product obtained in step a) with the pH of the water for the hydrolysis being reduced before the hydrolysis or that of the alkaline mother liquor being reduced during or after the hydrolysis, to a value of from 4 to 11, preferably from 5 to 10, by means of an acid, c) isolation of the hydrolysis product which has precipitated in step b), preferably at a pH of from 4 to 11, in particular from 5 to 10, and optionally washing and optionally drying and d) calcination of the hydrolysis product obtained in step c) at a temperature of from 700 to 1400° C., in particular from 800 to 1300° C.

Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array, and in particular an A?1-peptide-VLP-composition. More specifically, the invention provides a composition comprising a virus-like particle and at least one A?1-6 peptide bound thereto. The invention also provides a process for producing the conjugates and the ordered and repetitive arrays, respectively. The compositions of the invention are useful in the production of vaccines for the treatment of Alzheimer's disease and as a pharmaccine to prevent or cure Alzheimer's disease and to efficiently induce immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune, responses within the indicated context.

Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array. The invention also provides a process for producing an antigen or antigenic determinant in an ordered and repetitive array. The ordered and repetitive antigen or antigenic determinant is useful in the production of vaccines for the treatment of infectious diseases, the treatment of allergies and as a pharmaccine to prevent or cure cancer and to efficiently induce self-specific immune responses, in particular antibody responses.

Abstract: Process for reducing hexavalent chromium in oxidic solids, which comprises the steps: a) mixing of the oxidic solid containing Cr(VI) with a carbon-containing compound which is liquid in the range from 20 to 100° C., b) treatment of the mixture obtained after a) in an indirectly heated reactor at a temperature of from 700° C. to 1100° C., particularly preferably at a temperature of from 800° C. to 1000° C., under a protective atmosphere, c) cooling of the reaction product obtained after b) to at least 300° C., preferably at least 150° C., under a protective atmosphere.

Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array, and in particular an A?1-6 peptide-VLP-composition. More specifically, the invention provides a composition comprising a virus-like particle and at least one A?1-6 peptide bound thereto. The invention also provides a process for producing the conjugates and the ordered and repetitive arrays, respectively. The compositions of the invention are useful in the production of vaccines for the treatment of Alzheimer's disease and as a pharmaccine to prevent or cure Alzheimer's disease and to efficiently induce immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context.

Abstract: Process for preparing chromium(III) oxide, which comprises the steps: a) reaction of sodium monochromate with gaseous ammonia, in particular at a temperature of from 200 to 800° C., b) hydrolysis of the reaction product obtained in step a) with the pH of the water for the hydrolysis being reduced before the hydrolysis or that of the alkaline mother liquor being reduced during or after the hydrolysis, to a value of from 4 to 11, preferably from 5 to 10, by means of an acid, c) isolation of the hydrolysis product which has precipitated in step b), preferably at a pH of from 4 to 11, in particular from 5 to 10, and optionally washing and optionally drying and d) calcination of the hydrolysis product obtained in step c) at a temperature of from 700 to 1400° C., in particular from 800 to 1300° C.

Abstract: The present invention relates to a process for preparing chromium(III) oxide by reaction of alkali metal chromate with gaseous ammonia, subsequent hydrolysis, isolation of the hydrolysis product and calcination.

Abstract: Process for preparing ammonium dichromate, comprising the steps of c) thermally decomposing an alkali metal ammonium chromate double salt, especially a sodium ammonium chromate double salt or hydrates thereof, at a temperature up to 200° C., especially of 75 to 190° C., to form ammonium dichromate and d) removing the ammonium dichromate from the decomposition product obtained after step c), by crystallization, characterized in that the alkali metal ammonium chromate double salt corresponds to the formula Mx(NH4)yCrO4 or hydrates thereof, in which M is Na or K, particular preference being given to Na, x is from 0.1 to 0.9, preferably from 0.4 to 0.7, y is from 1.1 to 1.9, preferably from 1.3 to 1.6, and the sum of x and y is 2.

Abstract: Process for preparing chromium(III) oxide, comprising the steps of: a) Decomposing an alkali metal ammonium chromate double salt at a temperature of 200 to 650° C., especially of 250 to 550° C., b) washing the decomposition product obtained after a) and c) calcining the product obtained after b) at a temperature of 700 to 1400° C., especially of 800 to 1300° C.

Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array. The invention also provides a process for producing an antigen or antigenic determinant in an ordered and repetitive array. The ordered and repetitive antigen or antigenic determinant is useful in the production of vaccines for the treatment of infectious diseases, the treatment of allergies and as a pharmaccine to prevent or cure cancer and to efficiently induce self-specific immune responses, in particular antibody responses.

Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array, and in particular an A?1-6 peptide-VLP-composition. More specifically, the invention provides a composition comprising a virus-like particle and at least one A?1-6 peptide bound thereto. The invention also provides a process for producing the conjugates and the ordered and repetitive arrays, respectively. The compositions of the invention are useful in the production of vaccines for the treatment of Alzheimer's disease and as a pharmaccine to prevent or cure Alzheimer's disease and to efficiently induce immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context.

Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array. The invention also provides a process for producing an antigen or antigenic determinant in an ordered and repetitive array. The ordered and repetitive antigen or antigenic determinant is useful in the production of vaccines for the treatment of infectious diseases, the treatment of allergies and as a pharmaccine to prevent or cure cancer and to efficiently induce self-specific immune responses, in particular antibody responses.

Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array. The invention also provides a process for producing an antigen or antigenic determinant in an ordered and repetitive array. The ordered and repetitive antigen or antigenic determinant is useful in the production of vaccines for the treatment of infectious diseases, the treatment of allergies and as a pharmaccine to prevent or cure cancer and to efficiently induce self-specific immune responses, in particular antibody responses.

Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array, and in particular an A?1-6 peptide-VLP-composition. More specifically, the invention provides a composition comprising a virus-like particle and at least one A?1-6 peptide bound thereto. The invention also provides a process for producing the conjugates and the ordered and repetitive arrays, respectively. The compositions of the invention are useful in the production of vaccines for the treatment of Alzheimer's disease and as a pharmaccine to prevent or cure Alzheimer's disease and to efficiently induce immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context.

Abstract: A fuel pump (14) pumps fuel in a method for operating an internal combustion engine (10). The fuel pump (14) is connected at its input end to a fuel tank (12). Fuel reaches at least one combustion chamber (22) of the engine (10) via at least one fuel-injection device (16). In order to be able to inject fuel with still greater accuracy into the combustion chamber (22) of the engine (10), the fuel quantity which arrives in the combustion chamber (22) is determined from the signal of a through-flow measuring device (18).

Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array, and in particular an A&bgr;1-6 peptide-VLP-composition. More specifically, the invention provides a composition comprising a virus-like particle and at least one A&bgr;1-6 peptide bound thereto. The invention also provides a process for producing the conjugates and the ordered and repetitive arrays, respectively. The compositions of the invention are useful in the production of vaccines for the treatment of Alzheimer's disease and as a pharmaccine to prevent or cure Alzheimer's disease and to efficiently induce immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context.

Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array. The invention also provides a process for producing an antigen or antigenic determinant in an ordered and repetitive array. The ordered and repetitive antigen or antigenic determinant is useful in the production of vaccines for the treatment of infectious diseases, the treatment of allergies and as a pharmaccine to prevent or cure cancer and to efficiently induce self-specific immune responses, in particular antibody responses.